Slc6a13tm2e(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Slc6a13tm2e(KOMP)Wtsi |
Name: |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13; targeted mutation 2e, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4364505 |
Gene: |
Slc6a13 Location: Chr6:121277247-121314680 bp, + strand Genetic Position: Chr6, 57.22 cM, cytoband F1
|
IMPC: |
Slc6a13 gene page |
|
Mutant Cell Lines: |
EPD0154_1_E10, EPD0154_1_F08, EPD0154_1_G09, EPD0154_1_G10 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 121300741 of Chromosome 6 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. Insertion of this cassette creates a reporter knockout mouse. Cre expression will remove the neomycin selection cassette. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Slc6a13 Mutation: |
46 strains or lines available
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|